| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/11/2001 | WO2001002544A1 Process for producing l-amino acid |
| 01/11/2001 | WO2001002543A1 Process for producing l-amino acid |
| 01/11/2001 | WO2001002542A1 Process for producing l-amino acid |
| 01/11/2001 | WO2001002541A2 Compositions and methods for regulating abscisic acid-induced closure of plant stomata |
| 01/11/2001 | WO2001002540A2 Adenoviral vectors for treating disease |
| 01/11/2001 | WO2001002538A1 Substrates for nucleic acid immobilization onto solid supports |
| 01/11/2001 | WO2001002440A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | WO2001002439A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | WO2001002436A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | WO2001002434A1 Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
| 01/11/2001 | WO2001002433A1 Keratinocyte growth factor-2 |
| 01/11/2001 | WO2001002431A1 Recombinant adenovirus |
| 01/11/2001 | WO2001002430A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 01/11/2001 | WO2001002418A1 Method and system for rna analysis by matched ion polynucleotide chromatography |
| 01/11/2001 | WO2001002417A1 Nucleotide monomer containing six-membered azarsugar and antisense oligomers thereof |
| 01/11/2001 | WO2001002020A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 01/11/2001 | WO2001002019A2 Control of gene expression |
| 01/11/2001 | WO2001001767A1 Hydrocephaly model animals |
| 01/11/2001 | WO2001001766A1 Animal defective in uti gene function |
| 01/11/2001 | WO2001001762A1 Construction of rice tolerant to iron deficiency |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000066604A3 L-ribo-lna analogues |
| 01/11/2001 | WO2000063364A3 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/11/2001 | WO2000063356A3 Herbicidal seed treatment |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000061793A3 Novel method for identifying antibacterial compounds |
| 01/11/2001 | WO2000061770A3 Enhancement of the immune response for vaccine and gene therapy applications |
| 01/11/2001 | WO2000061747A3 Clasp-2 transmembrane proteins |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000055302A3 Genetically modified plants having modulated brassinosteroid signaling |
| 01/11/2001 | WO2000054770A8 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/11/2001 | WO2000054731A3 Syndesmos and uses thereof |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000053746A3 Method of delaying or inhibiting sprouting in plants |
| 01/11/2001 | WO2000053738A3 Methods and compositions for regulating memory consolidation |
| 01/11/2001 | WO2000053216A3 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 01/11/2001 | WO2000050075A3 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000046251A3 Human polyclonal antibodies from transgenic nonhuman animals |
| 01/11/2001 | WO2000039278A8 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 01/11/2001 | WO2000037679A3 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 01/11/2001 | WO2000029561A8 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/11/2001 | WO2000029551B1 Cells, culture methods, and their use in autologous transplantation therapy |
| 01/11/2001 | WO2000029012A8 Methods of alleviating cancer symptoms |
| 01/11/2001 | WO1995016779A9 Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | DE19931834A1 Identifizierung und Überexpression einer DNA-Sequenz codierend für eine 2-Methyl-6-phytylhydrochinon-methyltransferase in Pflanzen Identification and over-expression of a DNA sequence coding for a 2-methyl-6-phytylhydrochinon-methyltransferase in plant |
| 01/11/2001 | DE19931380A1 Verfahren zur rekombinanten Herstellung von Ribonukleoproteinen A method for the recombinant production of ribonucleoproteins |
| 01/11/2001 | DE19931317A1 L-Lysin produzierende coryneforme Bakterien und Verfahren zur Herstellung von L-Lysin L-Lysine-producing coryneform bacteria and method for producing L-lysine |
| 01/11/2001 | DE19931314A1 L-Lysin produzierende coryneforme Bakterien und Verfahren zur Herstellung von Lysin L-Lysine-producing coryneform bacteria and method for preparing lysine |
| 01/11/2001 | DE19930570A1 Pflanzen mit veränderter Genexpression Plants with altered gene expression |
| 01/11/2001 | DE19930433A1 New tetrameric Fv antibody construct having high affinity for antigen without causing immune reactions, useful for treating tumors and infections |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | DE19929485A1 Lytisches Enzym Lytic enzyme |
| 01/11/2001 | DE19926068C1 Muteine des Bilin-Bindungsproteins Muteins of the bilin-binding protein |
| 01/11/2001 | CA2750854A1 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | CA2590625A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phospho-transferase system proteins |
| 01/11/2001 | CA2590403A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phospho-transferase system proteins |
| 01/11/2001 | CA2399045A1 Keratinocyte growth factor-2 |
| 01/11/2001 | CA2389492A1 Magnetic particle composition |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2379477A1 Plants with modified gene expression |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2378573A1 Method for high-throughput selection of binding partners |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | CA2378423A1 Plants expressing .delta.6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids |
| 01/11/2001 | CA2378324A1 Recombinant adenovirus |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2378143A1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377932A1 Control of gene expression in eukaryotic cells |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377929A1 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
| 01/11/2001 | CA2377899A1 Methods, compositions and genetic sequences for modulating flowering in plants, and plants genetically modified to flower early and tardily |
| 01/11/2001 | CA2377804A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | CA2377795A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | CA2377793A1 Gene encoding cyclic lipopeptide acylase and expression of the same |
| 01/11/2001 | CA2377791A1 Novel polypeptide and dna thereof |
| 01/11/2001 | CA2377788A1 Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
| 01/11/2001 | CA2377784A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 01/11/2001 | CA2377780A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | CA2377768A1 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | CA2377731A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | CA2377381A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | CA2377378A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phosphotransferase system proteins |
| 01/11/2001 | CA2377107A1 Delivery of trefoil peptides |
| 01/11/2001 | CA2376619A1 Detection using dendrimers bearing labels and probes |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2376166A1 Control of gene expression |
| 01/11/2001 | CA2374386A1 Plant proteins |
| 01/11/2001 | CA2373352A1 Adenoviral vectors for treating disease |
| 01/11/2001 | CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | CA2372742A1 Double transgenic animals as models for neurodegenerative disease |
| 01/10/2001 | EP1067193A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/10/2001 | EP1067192A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/10/2001 | EP1067191A2 DNA coding for mutant isopropylmalate synthase, L-leucine-producing microorganism and method for producing L-leucine |
| 01/10/2001 | EP1067190A1 Gene therapy for enhancing and/or inducing angiogenesis |
| 01/10/2001 | EP1067189A1 Gene encoding flavone synthase |
| 01/10/2001 | EP1067188A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR) |